Preloader
Global Microbial Fermentation Technology Market Size, Trends & Growth Opportunity, By Application (Antibiotics, Probiotics Supplements, Monoclonal Antibodies, Recombinant Proteins, Biosimilars, Vaccines, Enzymes, Small Molecules, Others), By End-user (Bio-Pharmaceutical Companies, Contract Research Organizations (CROs), CMOs & CDMOs, Academic & Research Institutes), By Region and Forecast till 2030.


Report ID : IR1002252 | Industries : Healthcare | Published On :June 2024 | Page Count : 247

  • Request Sample      Ask for Customization     Inquire Before Buying     Speak to Analyst



  • Global Microbial Fermentation Technology Market Size, Trends & Growth Opportunity, By Application (Antibiotics, Probiotics Supplements, Monoclonal Antibodies, Recombinant Proteins, Biosimilars, Vaccines, Enzymes, Small Molecules, Others), By End-user (Bio-Pharmaceutical Companies, Contract Research Organizations (CROs), CMOs & CDMOs, Academic & Research Institutes), By Region and Forecast till 2030.
     

    Global Microbial Fermentation Technology Market.
    The global Microbial Fermentation Technology market was valued at USD 29.78 billion in 2022 which expected to reach USD 43.67 billion by 2030 at a CAGR 4.8%  from 2023-2030.
    Microbial fermentation technology is a cutting-edge field that uses microbes to create useful chemicals. Fungi, bacteria, and eukaryotic cells like insect cells and CHO cells are still being researched for possible use in the chemical, pharmaceutical, energy, material, and food industries. Microorganisms such as bacteria, yeasts, and fungi, as well as their enzymes, participate in fermentation. Based on DNA sequences, the biotechnology programme picks bacteria strains for fermentation.
    Market Drivers
    Factors such as rising biologics demand, the development of novel therapeutics based on smaller biologic drug molecules, and developments in microbial fermentation platforms/technologies have all contributed to the industry's rise in recent years. The microbial fermentation space has seen an increase in demand in recent years as the microbial biopharmaceutical industry has grown at an exponential rate. 
    Impact of COVID-19
    The microbial fermentation technology market was mostly unaffected by the COVID-19 outbreak. The increased demand for diverse biologics has shifted focus to microbial biotechnology. Microbial expression methods have also been used by market participants participating in COVID-19 vaccine development and manufacture. For example, the Pfizer-BioNTech vaccine relies on bacterial fermentation to produce the DNA plasmids required for vaccine manufacture.
    Market Segmentation
    The Global Microbial Fermentation Technology Market is segmented into Application, End-user. By Application such as Antibiotics, Probiotics Supplements, Monoclonal Antibodies, Recombinant Proteins, Biosimilars, Vaccines, Enzymes, Small Molecules, Others. Further, market is segmented into By End-user such as Bio-Pharmaceutical Companies, Contract Research Organizations (CROs), CMOs & CDMOs, Academic & Research Institutes.
    Regional Analysis
    Global Microbial Fermentation Technology Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. Asia Pacific dominated the market.  This is owing to Asian countries' recognition as a biopharmaceutical outsourcing hub. Asian enterprises, both domestic and multinational, are expected to construct around half of all new bioprocessing facilities worldwide. Many bioprocessing plants, for example, are scheduled to be built in China to suit domestic demand. The convergence of the aforementioned elements would raise the region's need for microbial fermentation technology.
    North America is predicted to grow rapidly in the future years. This might be ascribed to the increasing involvement of corporations in biologics research and product development, as well as the existence of a large number of contract development organizations in the region. Another important aspect driving the North American economy is a strong regulatory structure. The US FDA is still working to strengthen criteria for the promotion, development, approval, and legal practice of biopharmaceutical goods.
    Key Players
    Various key players are listed in this report such as Biocon Ltd, BioVectra Inc., F. Hoffmann-La Roche AG, Koninklijke DSM NV, Lonza, Novozymes A/S, TerraVia Holdings, Inc., BIOZEEN 
    Market Taxonomy
    By Application

    • Antibiotics
    • Probiotics Supplements
    • Monoclonal Antibodies
    • Recombinant Proteins
    • Biosimilars
    • Vaccines
    • Enzymes
    • Small Molecules
    • Others
    By End-user
    • Bio-Pharmaceutical Companies
    • Contract Research Organizations (CROs)
    • CMOs & CDMOs
    • Academic & Research Institutes
    By Region
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East & Africa
    Key Questions Addressed by the Report
    • What are the Key Opportunities in Global Microbial Fermentation Technology Market?
    • What will be the growth rate from 2023 to 2030?
    • Which segment/region will have highest growth?
    • What are the factors that will impact/drive the Market?
    • What is the competitive Landscape in the Industry?
    • What is the role of key players in the value chain?

    Global Microbial Fermentation Technology Market 
    1 Introduction 
    1.1 Objective of the Study
    1.2 Market definition
    1.3 Market Scope
    2 Research Methodology
    2.1 Data Mining
    2.2 Validation
    2.3 Primary Interviews
    2.4 List of Data Sources
    3 Executive Summary
    4 Global Microbial Fermentation Technology Market Outlook
    4.1 Overview
    4.2 Market Dynamics
    4.2.1 Drivers
    4.2.2 Restraints
    4.2.3 Opportunities
    4.2.4 Cumulative Impact due to recent Energy Crisis
    4.2.5 Cumulative Impact due to nearing economic downturn 
    4.2.6 Post covid-19 world Supply& Demand conditions
    4.2.7 Cumulative Impact of Russia-Ukraine Conflict
    4.3 Porters Five Force Model
    4.4 Value Chain Analysis
    5 Global Microbial Fermentation Technology Market, By Application
    5.1 Y-o-Y Growth Comparison, By Application 
    5.2 Global Microbial Fermentation Technology Market Share Analysis, By Application 
    5.3 Global Microbial Fermentation Technology Market Size and Forecast, By Application
    5.3.1 Antibiotics
    5.3.2 Probiotics Supplements
    5.3.3 Monoclonal Antibodies
    5.3.4 Recombinant Proteins
    5.3.5 Biosimilars
    5.3.6 Vaccines
    5.3.7 Enzymes
    5.3.8 Small Molecules
    5.3.9 Others
    6 Global Microbial Fermentation Technology Market, By End-user
    6.1 Y-o-Y Growth Comparison, By End-user
    6.2 Global Microbial Fermentation Technology Market Share Analysis, By End-user
    6.3 Global Microbial Fermentation Technology Market Size and Forecast, By End-user
    6.3. 1 Bio-Pharmaceutical Companies
    6.3.2 Contract Research Organizations (CROs)
    6.3.3 CMOs & CDMOs
    6.3.4 Academic & Research Institutes
    7 Global Microbial Fermentation Technology Market, By Region
    7.1 Global Microbial Fermentation Technology Market Share Analysis, By Region
    7.2 Global Microbial Fermentation Technology Market Share Analysis, By Region
    7.3 Global Microbial Fermentation Technology Market Size and Forecast, By Region
    8 North America Microbial Fermentation Technology Market Analysis and Forecast (2023-2030)
    8.1 Introduction
    8.2 North America Microbial Fermentation Technology Market Share Analysis, By Application
    8.3 North America Microbial Fermentation Technology Market Size and Forecast, By End-user
    8.4 North America Microbial Fermentation Technology Market Size and Forecast, By Country
    8.5.1 U.S.
    8.6.2 Canada
    9.7.3 Mexico
    9 Europe Microbial Fermentation Technology Market Analysis and Forecast (2023-2030)
    9.1 Introduction
    9.2 Europe Microbial Fermentation Technology Market Share Analysis, By Application 
    9.3 Europe Microbial Fermentation Technology Market Size and Forecast, By End-user 
    9.4 Europe Microbial Fermentation Technology Market Size and Forecast, By Country
    9.5.1 Germany
    9.6.2 France
    9.7.3 UK
    9.8.4. Rest of Europe
    10 Asia Pacific Microbial Fermentation Technology Market Analysis and Forecast (2023-2030)
    10.1 Introduction
    10.2 Asia Pacific Microbial Fermentation Technology Market Share Analysis, By Application 
    10.3 Asia Pacific Microbial Fermentation Technology Market Size and Forecast, By End-user 
    10.4 Asia Pacific Microbial Fermentation Technology Market Size and Forecast, By Country
    10.5.1 China 
    10.6.2 Japan
    10.7.3 India
    10.8.4. Rest of Asia Pacific
    11 Latin America Microbial Fermentation Technology Market Analysis and Forecast (2023-2030)
    11.1 Introduction
    11.2 Latin America Microbial Fermentation Technology Market Share Analysis, By Application 
    11.3 Latin America Microbial Fermentation Technology Market Size and Forecast, By End-user 
    11.4 Latin America Microbial Fermentation Technology Market Size and Forecast, Country
    11.5.1. Brazil
    11.6.2. Rest of Latin America
    12 Middle East Microbial Fermentation Technology Market Analysis and Forecast (2023-2030)
    12.1 Introduction
    12.2 Middle East Microbial Fermentation Technology Market Share Analysis, By Application 
    12.3 Middle East Microbial Fermentation Technology Market Size and Forecast, By End-user 
    12.4 Middle East Microbial Fermentation Technology Market Size and Forecast, By Country
    12.5.1. Saudi Arabia
    12.6.2. UAE
    12.7.3. Egypt
    12.8.4. Kuwait
    12.9.5. South Africa
    13 Competitive Analysis
    13.1 Competition Dashboard
    13.2 Market share Analysis of Top Vendors
    13.3 Key Development Strategies
    14Company Profiles
    14.1 Biocon Ltd
    14.1.1 Overview
    14.1.2 Offerings
    14.1.3 Key Financials
    14.1.4 Business Segment & Geographic Overview
    14.1.5 Key Market Developments
    14.1.6 Key Strategies
    14.2. BioVectra Inc.
    14.2.1 Overview
    14.2.2 Offerings
    14.2.3 Key Financials
    14.2.4 Business Segment & Geographic Overview
    14.2.5 Key Market Developments
    14.2.6 Key Strategies
    14.3. F. Hoffmann-La Roche AG
    14.3.1 Overview
    14.3.2 Offerings
    14.3.3 Key Financials
    14.3.4 Business Segment & Geographic Overview
    14.3.5 Key Market Developments
    14.3.6 Key Strategies
    14.4 Koninklijke DSM NV
    14.4.1 Overview
    14.4.2 Offerings
    14.4.3 Key Financials
    14.4.4 Business Segment & Geographic Overview
    14.4.5 Key Market Developments
    14.4.6 Key Strategies
    14.5 Lonza
    14.5.1 Overview
    14.5.2 Offerings
    14.5.3 Key Financials
    14.5.4 Business Segment & Geographic Overview
    14.5.5 Key Market Developments
    14.5.6 Key Strategies
    14.6 Novozymes A/S
    14.6.1 Overview
    14.6.2 Offerings
    14.6.3 Key Financials
    14.6.4 Business Segment & Geographic Overview
    14.6.5 Key Market Developments
    14.6.6 Key Strategies
    14.7 TerraVia Holdings, Inc. 
    14.7.1 Overview
    14.7.2 Offerings
    14.7.3 Key Financials
    14.7.4 Business Segment & Geographic Overview
    14.7.5 Key Market Developments
    14.7.6 Key Strategies 
    14.8 BIOZEEN
    14.8.1 Overview
    14.8.2 Offerings
    14.8.3 Key Financials
    14.8.4 Business Segment & Geographic Overview
    14.8.5 Key Market Developments
    14.8.6 Key Strategies